Rare Cancer Day Action Center

Thank you for joining TargetCancer Foundation in raising awareness and funds to support the rare cancer community.

 

✅ Your Rare Cancer Day 2023 checklist

☑️ Register for our Rare Cancer Day webinar being held on Thursday, October 5 at 12pm ET, “Clearing the Air About Clinical Trials: Facts, Myths and Potential Benefits”. Featuring oncologists and researchers Dr. James Cleary and Dr. Haley Ellis from Dana-Farber Cancer Institute and Massachusetts General Hospital, this webinar will provide a brief overview of clinical trials and how they work, discuss common myths, and explain why clinical trials can be an important tool for the treatment of rare cancers.

☑️ Learn about the upcoming 2023 Think Tank on Advancing Precision Medicine in Rare Cancers being held in Boston on Wednesday, November 15. Then watch the live Molecular Tumor Board session from the 2022 Think Tank on Advancing Precision Medicine in Rare Cancers, which showcases members of TRACK’s Investigator Team and Molecular Tumor Board, and provides a behind-the-scenes peek at one of the most critical components of the TRACK study.

☑️ Watch TargetCancer Foundation’s first webinar from the 2023 Lunch & Learn series, “It’s All in the Genes: The Differing Roles of Genomic and Genetic Testing in Precision Medicine”, held in June 2023. During this informative and engaging hour, Dr. Julia Elvin and Catherine Skefos, experts in the field of genomic and genetic testing, discussed these critical tools and the role they play in treating rare cancers.

☑️ Listen to the June 2023 Cancer Buzz podcast Leveraging Technology to Streamline Biomarker Testing featuring TCF CEO Jim Palma.

☑️ Listen to the inspiring story of our 2022 TargetCancer Foundation Gala Patient Keynote speaker Allen Chankowsky, author of On the Other Side of Terminal.

 

☑️  This week, Reps. Brian Fitzpatrick (R-PA), Brian Higgins (D-NY), Mike Kelly (R-PA) and Derek Kilmer ( D-WA) have introduced a bipartisan congressional resolution honoring Sept. 30^th as Rare Cancer Day. You can read the resolution here, and you can also read a press release featuring a statement by TargetCancer Foundation CEO and NORD Rare Cancer Coalition Founding Co-Chair Jim Palma.

☑️ Katie Doble is the Patient Keynote Speaker for the upcoming 2023 Think Tank on Advancing Precision Medicine in Rare Cancers. Katie wrote a powerful piece that was published by HuffPost in May about her remarkable journey facing a rare cancer, and the critical role clinical trials played in her treatment.

☑️ Learn about TCF-001 TRACK, TCF’s patient-driven precision medicine clinical trial focused on all rare cancers.

☑️ Read this article about the importance of genomic testing for rare cancer patients, co-written by TCF CEO Jim Palma, published in Conquer Magazine.

 

☑️ Support rare cancer research and patient initiatives by making a donation.

☑️ Sign up to receive notifications about future TCF Lunch & Learn webinars.

☑️ Follow us, like, and share our posts on Facebook, Instagram, Twitter, LinkedIn, and YouTube.

☑️ Share our infographics with your networks, tagging @TargetCancer and using the hashtag #RareCancerDay.